Skip to main content

Posts

Showing posts from May, 2022

The ROHHAD Market to grow on the basis of fostering frictionless navigation

  Hypoventilation, and Autonomic Dysregulation. ROHHAD is a rare syndrome whose etiology is not yet known. It is a pediatric disorder which potentially could be fatal. Symptoms of ROHHAD start appear in children generally after the age of 1-2 with rapid weight gain within a short span of six to 12-months span coupled with stunted height. The sequence of symptoms thereafter is hypothalamic and autonomic dysregulation. This is followed by behavioral issues. Prior to onset of obesity, the children appear to be otherwise healthy. The clinical symptoms of ROHHAD appear as the patient’s age advances. Early diagnosis of disorder holds the key in treatment of ROHHAD. It is a very rare disorder with only over 100 cases identified worldwide. ROHHAD essentially involves loss of respiratory control and autonomic nervous system (ANS) regulation, along with abnormalities in endocrine system. The disorder was first recognized in 1965. Currently, the cause of ROHHAD is known, howeve...

Clinical digital applications to safeguard the Protein Kinase Inhibitor Market

  Protein kinase is an enzyme that transfers phosphate collected from ATP (Adenosine Triphosphate) and rearranges the protein structure. It regulates variety of cell functions such as cell cycle, cell proliferation,apoptosis andcell differentiation. These cell processes are used to regulate various cell activities in cancer. The rising incidence of cancer diseases is expected to contribute towards the growth of the global protein kinase inhibitor market during the forecast period. The market is segmented on the basis of products, application and region. Based on product the market is segmented into serine/threorine protein kinase inhibitor and tyrosine protein kinase inhibitor. The tyrosine protein inhibitor is expected to dominate the market in this segment. The COVID 19 has already started to have an impact on protein kinase inhibitor market. The worldwide lockdowns may have resulted in lowering the sales of the market in current situation. However, the protein kinase inhibitor m...

The Humanized Mice Model Market To Be Driven By Value-Based Healthcare, Reaching US$ 113.5 Mn

The global Humanized Mice Model Market is expected to witness a  CAGR of 6.0%  and reach  US$ 113.5 Mn  by the year 2026. With how healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be the healthcare industry’s situation in the upcoming period. Persistence Market Research (PMR) has published a new research report on humanized mice model. The report has been titled,  “Humanized Mice Model Market: Global Industry Key Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2026.”  In order to extemporize pre-clinical studies, humanized mice models surface as a better solution. With further development in genomic analysis, there is also a chance of refinement in the mouse models. Get Sample Copy of this Report@  https://www.persistencemarketres...

Data Analytics To Usurp The Glycobiology Market, Reaching US$ 3.5 Bn

The Glycobiology Market is slated to grow at a  gracious rate of 13% , reaching  US$ 3.5 Bn  by the year 2030. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward. Extensive research related to carbohydrate molecules in various fields such as marine science and food & beverages is expected to fuel the growth of the global glycobiology market over the period of  2020  to  2030 . With most stakeholders present in North America, the market in the region will hold sway throughout the forecast period. Get Free Sample Copy of this Report@  https://www.persistencemarketresearch.com/samples/4769 The global  glycobiology market  is expected to expand at an impressive  CAGR of nearly 13%  from...

The Dysphagia Diet Thickening Agents Market To Go Blockchain Ways At A CAGR Of 5%

The global Dysphagia Diet Thickening Agents Market is all set to witness a  CAGR of 5%  in the next decade. It is expected to reach  US$ 715 Mn  by the year 2029. With digitized communication channels making a beeline to the healthcare vertical, the advanced clinics are into virtual consultation mode, and this scenario is expected to continue even going forward. Regulatory approvals for this type of communication are on the way. Close to 70% of the public hospitals worldwide are being asked to adopt digital means. This would be the scene with healthcare vertical in the subsequent period. Thickened liquids are utilized in the clinical management of dysphagia to prevent aspiration and improve bolus control. The use of thickening agents is not restricted to provide adequate viscosity, it also allows adequate hydration and nutrition, decreased risk of aspiration-related illness, and decreased risk of psychosocial effects. No pharmaceutical medication is availab...

Virtual Simulations To Create An Overhaul In The Indwelling Catheters Market, Reaching US$ 13.5 Bn

  The global   Indwelling Catheters Market  is expected to go great guns in the next 10 years. It is slated to reach   US$ 13.5 Bn   by the year 2031. The   CAGR would be 6.4% . With mixed reality in the foray, virtual objects could be integrated with the real-life ambiance, thereby rendering simultaneous manipulation of digital twins. In other words, digital twinning is expected to be the future of the healthcare vertical in the forecast period. According to a recent study by Persistence Market Research, the global indwelling catheters market is anticipated to witness high growth at  6.4% CAGR  and be valued at over  US$ 13.5 Bn  by 2031. Demand for indwelling catheters is surging with increasing geriatric population. With increasing age, the immune system becomes weak and people become more prone to illnesses and suffer from different diseases such as cancer and kidney diseases. According to Population Reference Bureau data o...

Advancements In Personalized Healthcare Through Regenerative Medicine To Drive The Endodontic Reparative Cement Market At A CAGR Of 4.2%

  The global   Endodontic Reparative Cement Market  is estimated to grow at the   rate of 4.2%   in the upcoming period, reaching   US$ 475.3 Mn   by the year 2031. Integration with virtual reality solutions is expected to rule the roost in the forecast period. Augmented reality could be used for accessing information as well as reports while handling patients or without having to leave their existing operations, that too, in a completely hands-free mode, through voice command, or making supportive data appear automatically. This would be the healthcare vertical in the future. According to a recent study by Persistence Market Research, the global endodontic reparative cement market is expected to witness high growth from  US$ 313.7 Mn  in 2021 to  US$ 475.3 Mn  by 2031 at  CAGR of around 4.2% . Growing number of endodontic procedures and introduction of technological advancements in endodontics are expected to boost m...

Cybersecurity To Be The Top Priority Of The Electrophysiology Ablation Market, Reaching US$ 6.3 Bn

  The   Electrophysiology Ablation Market   is likely to grow immensely, i.e. reach   US$ 6.3 Bn   at a   CAGR of 8.4%.   Physical health apps are gaining popularity. They are inclusive of calorie trackers, step-counters, and exercise and nutrition-based apps. These apps are to be at the forefront with regards to capitalizing on those having chronic ailments like high blood pressure, heart diseases, or diabetes. This would be a significant arm of the healthcare industry. According to a recent study by Persistence Market Research, the global electrophysiology ablation market is expected to witness high growth from  US$ 2.5 Bn  in 2021 to  US$ 6.3 Bn  by 2031. This reflects a  CAGR of around 8.4%  over the forecast period (2021-2031). Rising morbidity and mortality due to cardiac disorders, especially arrhythmia, make this market more demanding. Moreover, new product innovation and increased adoption of electrophys...

Remote Care Systems Through Digitization To Drive The Immunoassay Interference Blocker Market At A CAGR Of 6.7%

  The Immunoassay Interference Blocker Market is expected to grow on an irrevocable note in the upcoming period. The medical landscape is witnessing an influx of at-home diagnostic kits. This trend of on-demand products is likely to take the healthcare vertical by storm in the upcoming period. It has been observed that home kits aid in educating patients and bringing them to the medical visits better prepared, thereby curtailing the time taken for diagnosis. The status quo would help in keeping the healthcare vertical’s cash registers ringing going forward as well. As per Persistence Market Research’s latest revised industry analysis, the  global immunoassay interference blocker market  was valued at  US$ 223 Mn  in 2020, and is expected to exhibit a  CAGR of 6.7%  over the forecast period (2021-2031). Substances that modify quantifiable concentration of analytes or change antibody binding can conceivably result in immunoassay interference. Prevalence ...